Joseph D Khoury Selected Research

Sinus Histiocytosis (Rosai-Dorfman Disease)

1/2022	Cyclin D1 expression in Rosai-Dorfman disease: a near-constant finding that is not invariably associated with mitogen-activated protein kinase/extracellular signal-regulated kinase pathway activation.
1/2019	Focal Rosai-Dorfman disease coexisting with lymphoma in the same anatomic site: a localized histiocytic proliferation associated with MAPK/ERK pathway activation.
1/2014	A single case of rosai-dorfman disease marked by pathologic fractures, kidney failure, and liver cirrhosis treated with single-agent cladribine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joseph D Khoury Research Topics

Disease

54	Neoplasms (Cancer) 01/2022 - 05/2002
20	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 03/2014
11	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 10/2017
10	Lymphoma (Lymphomas) 01/2021 - 05/2002
9	Philadelphia Chromosome 01/2021 - 11/2015
8	Disease Progression 01/2022 - 04/2007
8	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2021 - 11/2016
7	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 04/2020 - 09/2003
6	Leukemia 01/2022 - 11/2018
5	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 11/2016
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 11/2015
4	Infections 12/2018 - 11/2015
3	Primary Myelofibrosis (Myelosclerosis) 02/2022 - 10/2015
3	Sinus Histiocytosis (Rosai-Dorfman Disease) 01/2022 - 01/2014
3	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 10/2017
3	B-Cell Lymphoma (Lymphoma, B Cell) 10/2021 - 12/2020
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2021 - 03/2014
3	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2008
3	Hodgkin Disease (Hodgkin's Disease) 12/2020 - 01/2017
3	Pathologic Complete Response 07/2020 - 11/2015
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2019 - 01/2003
3	Splenomegaly 01/2018 - 09/2016
2	Thrombocytopenia (Thrombopenia) 06/2022 - 01/2018
2	Necrosis 06/2021 - 01/2010
2	Lymphadenopathy 02/2021 - 01/2016
2	Plasmablastic Lymphoma 01/2021 - 08/2015
2	Hairy Cell Leukemia 10/2020 - 11/2018
2	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2020 - 01/2019
2	Pancreatitis 12/2018 - 11/2015
2	Hypertension (High Blood Pressure) 12/2018 - 11/2015
2	Exanthema (Rash) 12/2018 - 11/2015
2	Myocardial Infarction 12/2018 - 11/2015
2	Fibrosis (Cirrhosis) 01/2018 - 10/2015
2	Retinoblastoma (Glioblastoma, Retinal) 12/2017 - 03/2009
2	Breast Neoplasms (Breast Cancer) 03/2015 - 01/2010
2	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 05/2014 - 03/2014
2	Circulating Neoplastic Cells 12/2010 - 01/2010
2	Prostatic Neoplasms (Prostate Cancer) 12/2010 - 01/2010
2	Melanoma (Melanoma, Malignant) 08/2010 - 08/2009
2	Osteosarcoma (Osteogenic Sarcoma) 09/2008 - 07/2006
2	Neuroblastoma 01/2008 - 12/2007
2	Genetic Translocation (Chromosomal Translocation) 01/2008 - 07/2005
2	Rhabdomyosarcoma 09/2006 - 05/2006
2	Ewing Sarcoma (Sarcoma, Ewing) 07/2006 - 07/2005

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2004
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2016
5	Cyclin D1IBA 01/2022 - 01/2003
5	venetoclaxIBA 01/2022 - 01/2019
5	Biological ProductsIBA 10/2021 - 09/2007
4	Vincristine (Oncovin)FDA LinkGeneric 10/2021 - 11/2015
4	Tyrosine Kinase InhibitorsIBA 01/2021 - 11/2015
4	Transcription Factors (Transcription Factor)IBA 01/2021 - 07/2005
3	Transaminases (Aminotransferases)IBA 06/2022 - 01/2018
3	fms-Like Tyrosine Kinase 3IBA 01/2022 - 12/2017
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022 - 09/2006
3	Rituximab (Mabthera)FDA Link 10/2021 - 04/2017
3	ponatinibIBA 01/2021 - 11/2015
3	ChromatinIBA 01/2021 - 05/2002
3	Reticulin (Reticular Fiber)IBA 01/2018 - 10/2015
3	ParaffinIBA 01/2010 - 09/2003
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 06/2022 - 11/2015
2	Mitogen-Activated Protein KinasesIBA 01/2022 - 08/2009
2	Azacitidine (5 Azacytidine)FDA Link 01/2022 - 12/2017
2	c-Mer Tyrosine KinaseIBA 01/2022 - 01/2021
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2022 - 01/2022
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2021 - 01/2021
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021 - 01/2021
2	Dexamethasone (Maxidex)FDA LinkGeneric 10/2021 - 01/2021
2	S100 Proteins (S 100 Protein)IBA 06/2021 - 01/2019
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021 - 10/2015
2	Inotuzumab OzogamicinIBA 01/2021 - 01/2018
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021 - 08/2009
2	ofatumumab FDA Link 01/2021 - 07/2020
2	blinatumomabIBA 01/2021 - 01/2018
2	Pharmaceutical PreparationsIBA 01/2021 - 12/2017
2	LigandsIBA 01/2020 - 01/2020
2	CateninsIBA 01/2020 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2019
2	Prednisone (Sone)FDA LinkGeneric 12/2018 - 11/2015
2	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2018 - 02/2017
2	CollagenIBA 10/2015 - 09/2007
2	RNA (Ribonucleic Acid)IBA 08/2015 - 08/2013
2	fibrin fragment D (D-dimer)IBA 03/2015 - 12/2010
2	Imatinib Mesylate (Gleevec)FDA Link 03/2014 - 11/2013
2	Prostate-Specific Antigen (Semenogelase)IBA 12/2010 - 01/2010
2	ErbB Receptors (EGF Receptor)IBA 09/2008 - 09/2006
2	Formaldehyde (Formol)FDA Link 08/2005 - 09/2003

Therapy/Procedure

52	Therapeutics 01/2022 - 04/2004
17	Drug Therapy (Chemotherapy) 10/2021 - 04/2007
9	Radiotherapy 10/2021 - 07/2006
3	Breast Implants (Breast Implant) 04/2020 - 06/2018
3	Consolidation Chemotherapy 01/2020 - 01/2018
3	Precision Medicine 11/2019 - 01/2016
2	Hematopoietic Stem Cell Transplantation 02/2022 - 11/2018
2	Salvage Therapy 01/2021 - 03/2009
2	Aftercare (After-Treatment) 10/2020 - 07/2006
2	Stem Cell Transplantation 07/2020 - 11/2018
2	Immunotherapy 01/2020 - 01/2020
2	Castration 12/2010 - 01/2010